AGFA HealthCare
MORTSEL, BELGIUM / ACCESSWIRE / May 14, 2024 / AGFA HealthCare is pleased to announce that St. Vincent's Private Hospital in Dublin, Ireland, has chosen to implement AGFA HealthCare's Enterprise Imaging. This five-year agreement includes Enterprise Imaging for both Radiology and Breast Imaging, structured and precision reporting modules, Best in KLAS XERO® Universal Viewer, AGFA's Scheduling solution, Business Intelligence, Patients and Clinician portal, and a Managed Services contract.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.Near-real-time image access
St. Vincent's Private Hospital is the largest acute private hospital in Dublin and part of the only integrated multi-hospital campus in Ireland. The Enterprise Imaging Platform will deliver the advanced capabilities and robust availability that the hospital needs.
"St. Vincent's Private Hospital is a unique healthcare environment. As we are on the same grounds as St. Vincent's University Hospital, we can share resources, expertise and medical facilities with this leading academic teaching establishment. This enables us to deal with a high volume of patients, often who have complex medical requirements. Imaging is core to this care. AGFA HealthCare's Enterprise Imaging will give us the reliable, robust platform that we need, whilst delivering very fast access to studies. Furthermore, AGFA HealthCare is able to support this system with managed services and monitoring that will maximise our uptime, while minimising the burden on our own resources," says Tim Aseervatham, Healthcare/Diagnostic Informatics Manager for St. Vincent's Private Hospital.
"We are proud of the trust that St. Vincent's Private Hospital - a key healthcare player in Ireland - is placing in AGFA HealthCare. This further demonstrates the success of our long-standing commitment to delivering solutions that improve the delivery of healthcare to patients in both the private and public healthcare sector in Ireland and beyond. Enterprise Imaging enables the creation of a secure, modular and scalable ecosystem, which helps the hospital to reduce complexity, improve clinical collaboration, and enhance workflow efficiency. By empowering all users to access imaging studies in near-real-time, it will allow them to focus on tasks that add value to both their patients' care and experience," says Colin Foley, Regional Business Manager for AGFA HealthCare Ireland.
Seamless care and collaboration
The Radiology Department at St. Vincent's Private Hospital is one of the largest radiology services in the country, offering a full range of diagnostic and interventional services. It performs over 65,000 studies every year, including X-ray, CT, mammography, MRI, ultrasound, fluoroscopy and DEXA. The department is made up of 18 consultant radiologists working in conjunction with highly qualified radiographers and nurses and supported by experienced administrators.
Enterprise Imaging will integrate with the hospital's existing pillar and patient referral systems and will replace all paper-based workflows. The five-year agreement includes:
- Enterprise Imaging for Radiology and Breast Imaging: a one-of-a-kind, seamless and secure platform designed to build a connected, collaborative, and scalable community of care. Enterprise Imaging delivers "life in flow" to meet radiologists' daily challenges through a highly focused, efficient and customisable experience.
- Best in KLAS XERO® Universal Viewer: provides patient-centric image access across the enterprise, with pixel streaming in near-real time on almost any device with no downloads or data moves, and enhanced viewing with clinical depth, collaboration and sharing, all on a single web viewer.
- Business Intelligence: enables easy-to-access reports and tools for gathering, organising, analysing and managing clinical, quality, financial and administrative data.
- Scheduling: facilitates managing appointments and orders for even the most complex imaging procedures in one easy and quick web-based application.
- Structured and precision reporting, including ACR BI-RADS® ATLAS and ACR PI-RADS® ATLAS: fully integrated in the Enterprise Imaging Platform, it combines customisation with automation to support clear communication and enhanced decision-making.
- Workflow orchestration: intelligently and automatically assigns tasks to radiologists, based on the chosen criteria.
- Collaboration tools: support multidisciplinary teams with the multimedia patient images they need, wherever they are, including at the point of care.
- Actionable findings notification: closes the loop between radiologists and clinicians through rapid and effective communication of incidental and critical imaging findings.
- Native 3D tools and advanced visualisation, plus seamlessly embedded third-party clinical application.
- Portal for patients and physicians: makes it easy for patients and physicians outside of the hospital to access medical images and results.
- Managed services and monitoring: support optimal maintenance and uptime of this flexible and high-performance solution.
We are delighted to welcome St Vincent's Hospital to #TeamAGFA and are honoured to add such a prestigious hospital to our customer base.
About AGFA HealthCare
At AGFA HealthCare, we are transforming the delivery of care - supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management. As a company, we are dedicated to our customers, and we have harnessed a value framework of Mission, Vision and Customer Delivery Principles into our routine operations. Through these principles, we commit a consistent high-yield code of conduct to our associates - channelling our experience and aspirations to all of our stakeholders. Our Empowerer profile supports our focus on creating an exceptional experience through the power of technology and is an integral foundation to our company standards. AGFA HealthCare is a division of the Agfa-Gevaert Group. For more information on AGFA HealthCare, please visit www.agfahealthcare.com and follow us on LinkedIn.
AGFA and the Agfa rhombus are registered trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. XERO® is a registered trademark of AGFA HealthCare N.V., Belgium. BI-RADS and PI-RADS are registered trademarks of the American College of Radiology. All rights reserved. All information contained herein is intended for guidance purposes only, and the characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. AGFA HealthCare diligently strives to provide as accurate information as possible but shall not be responsible for any typographical error.
Contact Information
Buse Kayar
buse.kayar@issuerdirect.com
SOURCE: AGFA HealthCare
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Clean Air Metals Announces 2026 Strategic Objectives in Historically Strong PGE and Copper Markets13.1.2026 01:10:00 CET | Press release
THUNDER BAY, ON / ACCESS Newswire / January 12, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR)(FRA:CKU0(OTCQB:CLRMF) is pleased to provide an overview of its 2026 objectives and highlights of 2025, for its 100%-owned Thunder Bay North ("TBN") Critical Minerals Project in Northwestern Ontario. Critical Project Advancement Objectives Spot prices for platinum, copper and palladium have appreciated by 70% (1000 $/oz), 25% (1.20 $/lb) and 50% 624($/oz) respectively versus study prices, since the results of the Preliminary Economic Assessment (PEA) were announced in the October 9th release. Using the financial model published in the PEA and applying current spot metal prices (as of January 6th), the TBN project shows a $708M1 NPV8 and a pre-tax IRR of 100% (post-tax NPV8 = $494M1 and IRR = 84%).This is a significant improvement in the project outlook in comparison to the PEA results that featured a $219.4M2 pre-tax NPV8 and a pre-tax IRR of 39%. This year, cons
Germany Buys Eight MQ-9B SeaGuardian(R) RPA Through NSPA12.1.2026 20:00:00 CET | Press release
NSPA Supports NATO Countries in the Acquisition and Sustainment of GA-ASI's Advanced Multi-Domain RPA SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 12, 2026 / Germany's Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support and the NATO Support and Procurement Agency (NSPA) have announced the procurement of eight MQ-9B SeaGuardian® Remotely Piloted Aircraft (RPA) from General Atomics Aeronautical Systems, Inc. (GA-ASI). The program includes four Certifiable Ground Control Stations. First delivery is expected in 2028. Germany joins a growing list of NATO countries that have selected GA-ASI's advanced MQ-9B RPA for its multi-domain capabilities with exceptionally long range and endurance. The platform provides pole-to-pole satellite control and de-icing capabilities to enable missions in cold climates. SeaGuardian features two multi-mode surface-search radars that deliver wide-area maritime surveillance, with an option to add Anti-Submarine Warfare capa
Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target12.1.2026 14:05:00 CET | Press release
Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026. With the full deployment of Datavault AI's nodes across 100+ cities throughout the United States, the 2027 revenue target is $2.0 to $3.0 billion for 2027. New York and Philadelphia edge network activation positions Datavault AI to potentially capture a significant share of the insurance and financial sectors, the healthcare industry, and enterprise opportunities. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies, today highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform. This
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom